Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Essence (BIOE) EBT (2020 - 2025)

Bio Essence has reported EBT over the past 6 years, most recently at $1.0 million for Q4 2025.

  • For Q4 2025, EBT rose 3833.58% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $896997.0, up 157.32%, while the annual FY2025 figure was $896997.0, 157.32% up from the prior year.
  • EBT for Q4 2025 was $1.0 million at Bio Essence, up from $12998.0 in the prior quarter.
  • Over five years, EBT peaked at $1.0 million in Q4 2025 and troughed at -$1.2 million in Q3 2024.
  • A 5-year average of -$112028.7 and a median of -$141989.5 in 2022 define the central range for EBT.
  • Biggest five-year swings in EBT: plummeted 1041.83% in 2024 and later surged 3833.58% in 2025.
  • Year by year, EBT stood at -$90634.0 in 2021, then skyrocketed by 174.99% to $67964.0 in 2022, then plummeted by 369.33% to -$183048.0 in 2023, then soared by 84.94% to -$27563.0 in 2024, then surged by 3833.58% to $1.0 million in 2025.
  • Business Quant data shows EBT for BIOE at $1.0 million in Q4 2025, $12998.0 in Q3 2025, and $60664.0 in Q2 2025.